The board of directors of Angelalign Technology Inc. announced that Mr. HUANG Kun ("Mr. Huang"), a non-executive Director, has been re-designated and appointed to be an executive Director and the president of global business (ex-China) of the Company with effect from September 1, 2023. Mr. Huang has served as a Director of the Company for years and is familiar with the Company's business and development strategies. He has been driving and leading the Company's internationalization strategies since the listing of the Company and very involved in the global business operation and expansion of the Company.

Mr. Huang, as a partner of CareCapital, has been playing an instrumental role in strategy planning and international business expansion for both CareCapital and its portfolio companies, and maintaining an extensive network with enterprises and key opinion leaders (KOLs) in the global dental industry. He is also the co-chairman of the board of International Orthodontics Foundation Limited, an influential not- for-profit international research and education organization devoted to improving orthodontic care worldwide. The Company strives to become a worldwide leader in the field of digital orthodontics.

The Board believes that the experience and background of Mr. Huang is highly compatible with the Company's development strategy in globalization and will benefit the future development of the Company. Mr. HUANG Kun, aged 41, will serve as an executive Director and the president of global business (ex-China) of the Company with effect from September 1, 2023. Prior to his re-designation, Mr. Huang joined the Group in January 2015 as a director of Wuxi EA Medical Instruments Technologies Limited and was appointed as a non-executive Director in November 2018 and a member of the remuneration committee of the Board (the "Remuneration Committee") in June 2021.

He also serves as a director of certain of subsidiaries of the Company, including Wuxi EA, the major operating entity of the Group in China, and Angelalign Technology Pte. Ltd., the major international business operating entity of the Group. Mr. Huang joined CareCapital Advisors Limited, a global investment firm focusing on quality-of-life healthcare with oral health as a core focus in April 2015 and serves as a partner.

Mr. Huang is the co-chairman of the board of International Orthodontics Foundation Limited, a not-for-profit research and education organization devoted to improving orthodontic care worldwide. Prior to that, Mr. Huang served as a vice president of Beijing Warburg Pincus Consulting Co. Ltd. from July 2011 to March 2015 and as a senior investment manager of Orchid Asia Investment Consulting (Shanghai) Co.

Ltd. from June 2007 to June 2011. Mr. Huang graduated from Tsinghua University with a bachelor's degree in finance in July 2005. The Board announced that Mr. SONG Xin ("Mr. Song"), an executive Director, has been promoted from the chief commercial officer of the Company to the chief operating officer of the Company with effect from September 1, 2023.

Mr. Song has served as a Director of the Company for years and is familiar with the Company's business and development strategies, primarily responsible for the sales, marketing and treatment planing operation. The Board believes that the experience and background of Mr. Song are highly compatible with the Company's development strategy and will benefit the future development of the Company. Mr. SONG Xin, aged 37, is an executive Director and a member of the nomination committee of the Board, and has been appointed as the chief operating officer of the Company with effect from September 1, 2023.

Prior to his appointment, Mr. Song joined the Group in August 2011, and has been served as the chief commercial officer of the Company since February 2018 and an executive Director since April 2021. He also serves as a director of certain of subsidiaries of the Company, including Wuxi EA, the major operating entity of the Group in China, and Angelalign Technology Pte. Ltd., the major international business operating entity of the Group.

Prior to that, Mr. Song had served as a regional manager of Guizhou Tongjitang Pharmaceutical Co. Ltd. from March 2009 to July 2011. Mr. Song obtained his bachelor's degree in bio-technology from Henan University of Technology in July 2008 and is currently pursuing EMBA degree from Fudan University.